J.P. Morgan Maintains Underweight on MannKind (MNKD)

J.P. Morgan is out with its report today on MannKind MNKD, maintaining Underweight. In a note to clients, J.P. Morgan writes, "We maintain our UW on MNKD following the 1Q update post close. We remain surprised the company has maintained an ~$950M EV in the face of an increasingly tenuous financial position and questionable outlook for Afrezza." At the time of posting, shares of MNKD were trading pre-market at $3.78, down 14.09% from Friday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsBiotechnologyHealth CareJ.P. MorganMannKind
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!